Pancreatic cancer cells bearing KRAS mutations exhibit high levels of ROS and NO, suggesting why biguanide AUTACs may be toxic to these cells, which likely have elevated levels of 8-nitro-cGMP. This evidence concerns the gene KRAS and pancreatic neoplasm.